Pharrell’s New Adidas Water Shoes Might Be His Wildest Sneakers Ever

Apple will launch its AI platform, Apple Intelligence, in China in December with Alibaba-developed safeguards, ending regulatory delays. The platform includes features like Genmoji and writing tools but excludes newer ones like Siri AI. Apple's market value briefly surpassed $5 trillion in New York, the second company to do so after Nvidia.

Nvidia will invest $250M in UK AI safety research over 5 years. CEO Jensen Huang defended the industry's approach to AI risks.

GlobalFoundries (GFS) will operate two new 300mm semiconductor plants in New York, funded by a $21B U.S.-Japan initiative. The move expands production capacity without additional capital expenditures. GFS is trading at $48.94, 6.1% above its GF Value™ of $46.14, with a GF Score™ of 84/100. Insiders have sold $3.8M in shares over the past year.

The U.S. and Japan agreed to build two semiconductor plants in Malta, New York, with $21B investment. GLOBALFOUNDRIES Inc. will operate them, creating jobs and boosting domestic production. Apple and Renesas are initial customers. The project aims to reduce reliance on overseas semiconductors.

Tesla claims its Cybercab fleet in Austin has grown to over 300 vehicles in 30 days, though independent sources suggest the active fleet may be smaller. Texas vehicle registry data shows 319 Cybercabs and 420 Model Y robotaxis, totaling 739 vehicles, but Waymo still leads with 1,185 registered vehicles. Federal regulators seek answers from Tesla by month's end.

Takeda Pharmaceutical has launched ORZEYFUL, a new treatment for type 1 narcolepsy, in Japan and China. The drug, discovered by Takeda scientists, is designed to restore orexin signaling and address the biological cause of the disease. Clinical studies showed significant improvements in symptoms and quality of life compared to placebo. ORZEYFUL is an oral orexin receptor 2 (OX2R) agonist, and Takeda plans to launch it in the U.S. next month.